UNETIXS VASCULAR, INC.

UNETIXS VASCULAR, INC. specializes in the design, development, and manufacturing of advanced vascular medical devices, operating within the precision instrumentation and medical equipment sector under NAICS 334510. The company’s technical expertise centers on minimally invasive interventional devices, including catheter-based systems, guidewires, and vascular access platforms engineered for clinical precision and biocompatibility. Their work involves high-tolerance manufacturing processes, materials science applications in polymers and metals, and regulatory-compliant quality systems aligned with FDA 21 CFR Part 820 and ISO 13485 standards. Key differentiators include proprietary device architectures optimized for complex vascular anatomy and a focus on reducing procedural complications through engineered reliability and ergonomic design. Award history is not available to confirm specific agency engagements, so no definitive patterns of federal contract performance can be inferred. The company’s market positioning is rooted in the medical device industry, serving clinical and surgical environments where device performance directly impacts patient outcomes. While no public procurement records indicate direct federal contracting activity, their technical domain aligns with potential applications in VA, DoD, and HHS healthcare delivery systems requiring advanced vascular intervention tools. As a small business structured as a 2L entity, UNETIXS VASCULAR, INC. is headquartered in Warwick, Rhode Island, with operations focused on high-precision manufacturing and product development. The company does not currently hold any formal government certifications such as 8(a), HUBZone, or SDVOSB status. Its geographic presence is localized, with capabilities concentrated in advanced medical device engineering and production, positioning it as a niche supplier within the broader U.S. cardiovascular device ecosystem.